DIFFERENT REGIOSPECIFICITY IN THE HYDROXYLATION OF THE ANTIDEPRESSANT DESMETHYLIMIPRAMINE BETWEEN RAT-BRAIN AND LIVER

被引:11
作者
HANSSON, T
VONBAHR, C
MARKLUND, M
SVENSSON, JO
INGELMANSUNDBERG, M
LUNDSTROM, J
机构
[1] KAROLINSKA INST,DEPT PHYSIOL CHEM,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN
[2] ASTRA RES CTR,DEPT DRUG METAB,S-15185 SODERTALJE,SWEDEN
[3] ASTRA RES CTR,DEPT CLIN PHARMACOL,S-15185 SODERTALJE,SWEDEN
[4] HUDDINGE UNIV HOSP,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
来源
PHARMACOLOGY & TOXICOLOGY | 1992年 / 71卷 / 06期
关键词
D O I
10.1111/j.1600-0773.1992.tb00571.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Incubation of the tricyclic antidepressant desmethylimpramine (DMI) with rat liver or brain microsomes in the presence of NADPH or t-butyl-hydroperoxide (TBH) revealed different regiospecificities in the hydroxylation reactions between the tissues. In brain preparations 10-OH-DMI was formed in reactions supported by NADPH or TBH, whereas in the latter case also an unidentified metabolite could be detected. Inclusion of exogenous NADPH-cytochrome P450 reductase in the brain preparations caused a 10-fold higher rate of 10-hydroxylation but no 2-OH-DMI could be detected. By contrast, liver microsomal preparations in the presence of NADPH catalyzed formation of both 2- and 10-OH-DMI, whereas only 10-OH-DMI was formed in TBH-supported reactions. The results indicate that antidepressant drugs can be metabolized in brain with different stereospecificity as compared to liver.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 23 条
[1]   QUINIDINE INHIBITS THE 2-HYDROXYLATION OF IMIPRAMINE AND DESIPRAMINE BUT NOT THE DEMETHYLATION OF IMIPRAMINE [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (02) :155-160
[2]  
DAS M, 1981, J PHARMACOL EXP THER, V216, P156
[3]   ENZYME-STRUCTURE RELATIONSHIPS IN ENDOPLASMIC RETICULUM OF RAT LIVER - A MORPHOLOGICAL AND BIOCHEMICAL STUDY [J].
ERNSTER, L ;
PALADE, GE ;
SIEKEVITZ, P .
JOURNAL OF CELL BIOLOGY, 1962, 15 (03) :541-+
[4]   N-DEMETHYLATION OF MORPHINE IN RAT-BRAIN IS LOCALIZED IN SITES WITH HIGH OPIATE RECEPTOR CONTENT [J].
FISHMAN, J ;
HAHN, EF ;
NORTON, BI .
NATURE, 1976, 261 (5555) :64-65
[5]   MPTP, THE NEUROTOXIN INDUCING PARKINSONS-DISEASE, IS A POTENT COMPETITIVE INHIBITOR OF HUMAN AND RAT CYTOCHROME-P450 ISOZYMES (P450BUFI, P450DB1) CATALYZING DEBRISOQUINE 4-HYDROXYLATION [J].
FONNEPFISTER, R ;
BARGETZI, MJ ;
MEYER, UA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :1144-1150
[6]   MOLECULAR-GENETICS OF THE P-450 SUPERFAMILY [J].
GONZALEZ, FJ .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :1-38
[7]   REGIONAL DISTRIBUTION OF ETHANOL-INDUCIBLE CYTOCHROME-P-450 IIE1 IN THE RAT CENTRAL-NERVOUS-SYSTEM [J].
HANSSON, T ;
TINDBERG, N ;
INGELMANSUNDBERG, M ;
KOHLER, C .
NEUROSCIENCE, 1990, 34 (02) :451-463
[8]  
INGELMANSUNDBERG M, 1984, J BIOL CHEM, V259, P6447
[9]   IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P-450 IN RAT-BRAIN [J].
KAPITULNIK, J ;
GELBOIN, HV ;
GUENGERICH, FP ;
JACOBOWITZ, DM .
NEUROSCIENCE, 1987, 20 (03) :829-833
[10]  
LLERNA A, 1990, DRUG METABOLIZING EN, P199